Stock picks with research | support | resistance and technical analysis for trading | Day trading | stock investing in the market
day investing picks penny stock trading
Skip Navigation Links
    •   About US
    Market Activity
    World Indices
    Market Watch
    Customer Service
    Learning Center
    Economic Event

Join Now

stock Breakout for day trading

advertise 2 ۩  Daily market forecast
Stock : EBS |   Stock Recommendations : Buy
Sector : Biotech & Drugs |   First resistance : 18.19
Stock Name : EMERGENT BIOSOLUTIONS INC COM |   Second resistance :
Buy Near : |   Third resistance :
StopLoss : |   First Support : 16.11
Posted date : 11/2/2008 12:00:00 AM |   Second Support : 14.60

Emergent BioSolutions Inc. com (EBS) Stock has given a buy signal, with rising moving average. Stockhastic and ADX also given a buy signal.

   Emergent BioSolutions Inc. com (EBS) announced on 10/1/08, it will receive between $364 million and $404 million for new contracts to supply the U.S. government with anthrax vaccines. Emergent BioSolutions Inc. com (EBS) is a Biotechnology company. As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. Emergent BioSolutions Inc. com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to Stock market and economic condition keep tight stop loss on all position. You can buy this Stock near $18

Portfolio stock

Recent News Head Lines
Is Emergent BioSolutions (EBS) a Good Stock to Pick Now?
(Wed, 18 Nov 2020 14:30:02 +0000)
Is Emergent BioSolutions (EBS) a great pick from the value investor's perspective right now? Read on to know more.
Arena (ARNA) Q3 Earnings Top, Stock Down on Eczema Study Data
(Tue, 10 Nov 2020 14:40:02 +0000)
Arena Pharmaceuticals (ARNA) beats bottom-line estimates for third-quarter 2020. Mid-stage atopic dermatitis study on etrasimod fails to meet primary endpoint but phase III study may start soon.
Deciphera (DCPH) Reports Narrower-Than-Expected Loss in Q3
(Mon, 09 Nov 2020 15:18:03 +0000)
Deciphera (DCPH) reports a narrower-than-expected loss and sales beat estimates in the third quarter of 2020.
Iovance (IOVA) Q3 Earnings Beat Estimates, Pipeline in Focus
(Mon, 09 Nov 2020 13:58:01 +0000)
Iovance's (IOVA) third-quarter earnings beat estimates. The company is progressing well with development of its lead pipeline candidate.
Why Emergent BioSolutions Slipped on Friday
(Fri, 06 Nov 2020 23:50:00 +0000)
Shareholders of vaccine and antibody therapy specialist Emergent BioSolutions (NYSE: EBS) were feeling a bit queasy on Friday afternoon. In its fiscal third quarter of 2020, Emergent BioSolutions enjoyed 24% year-over-year growth in total revenue, which landed at $385.2 million. Emergent BioSolutions saw a big revenue boost with sales of its two anthrax vaccines, Anthrasil and BioThrax.

Never go against major trend for day trading | stock trading

Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research

Contact Us | Affiliate | Disclaimer | Feedback | Help | Site Map | RSS  RSS
All Rights Reserved © 2000-2006
Chart courtesy of
Portfolio stock - EMERGENT BIOSOLUTIONS INC COM for Stock investing stock trading day trading

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.